BrainWaveBank
Seed Round in 2020
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.
BrainWaveBank
Venture Round in 2020
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.
See.Sense
Seed Round in 2019
See.Sense develops innovative cycling technology aimed at enhancing safety and convenience for cyclists. The company creates award-winning products that utilize patented sensor technology and artificial intelligence to improve the riding experience. With over 50,000 users globally, See.Sense is recognized as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data collected by its products supports collaboration with smart cities worldwide, aiming to enhance cycling infrastructure, reduce congestion, and improve urban mobility. The company is based in Northern Ireland and has received multiple awards for its design and innovation.
BrainWaveBank
Seed Round in 2019
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.
See.Sense
Seed Round in 2018
See.Sense develops innovative cycling technology aimed at enhancing safety and convenience for cyclists. The company creates award-winning products that utilize patented sensor technology and artificial intelligence to improve the riding experience. With over 50,000 users globally, See.Sense is recognized as the official bike light and ride insights supplier for British Cycling and Cycling Ireland. The unique data collected by its products supports collaboration with smart cities worldwide, aiming to enhance cycling infrastructure, reduce congestion, and improve urban mobility. The company is based in Northern Ireland and has received multiple awards for its design and innovation.
BrainWaveBank
Seed Round in 2017
BrainWaveBank, established in 2015, is a UK-based brain health research company. It specializes in developing data-centric solutions to track and understand cognitive health. The company's flagship product, also named BrainWaveBank, is a wearable EEG headset that measures brain activity while users engage in mobile games, enabling daily tracking of cognitive health at home. This data is securely stored and analyzed, creating neurocognitive profiles for individuals and populations, and aiding clinical professionals in advancing brain health research and treatments. The company has offices in Belfast, Northern Ireland, and Dublin, Ireland.
Autism Biotech
Non Equity Assistance in 2014
Autism Biotech is a company based in Belfast, Northern Ireland, focused on developing a biochemical test for the early and reliable diagnosis of autism spectrum disorder. Their product, ASDtect, utilizes peptide biomarkers protected by two granted patents to facilitate the detection of autism from a simple blood sample. This innovative approach aims to address a significant and largely untapped market, enhancing the ability of healthcare professionals to diagnose and subsequently treat individuals with autism. Currently, Autism Biotech is conducting clinical trials to ensure the efficacy of ASDtect, with plans to make the diagnostic test available in the near future.
Kelsius
Venture Round in 2012
Kelsius is a provider of automation technology focused on product safety and compliance within the food services and healthcare sectors. Founded in 2003 and headquartered in Donegal, Ireland, the company specializes in wireless temperature monitoring systems and a digital HACCP Management system. These technologies enhance product safety, ensure adherence to regulatory standards, and help optimize related costs. By reducing product wastage due to refrigerator malfunctions and improving food quality, Kelsius empowers clients to manage food safety more effectively through automated processes, ultimately leading to significant cost savings and increased labor efficiency.
PathXL
Venture Round in 2012
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.